Emodin inhibits tumor metastasis in breast cancer by disrupting TGF-β1-mediated TAM-cancer cell interactions to halt EMT and stem cell formation [448], and modulating AKT/ERK signaling to attenuate metastatic potential in obesity/hyperlipidemia [471]. This evidence concerns the gene AKT1 and breast carcinoma.